Literature DB >> 17925530

Combining carefully selected drug, patient genetics may lead to total tumor death.

Rabiya S Tuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17925530     DOI： 10.1093/jnci/djm194

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

Review 2.  DNA repair in cancer: emerging targets for personalized therapy.

Authors:  Rachel Abbotts; Nicola Thompson; Srinivasan Madhusudan
Journal:  Cancer Manag Res       Date:  2014-02-19       Impact factor: 3.989

3.  Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors.

Authors:  Ana M Mendes-Pereira; Sarah A Martin; Rachel Brough; Afshan McCarthy; Jessica R Taylor; Jung-Sik Kim; Todd Waldman; Christopher J Lord; Alan Ashworth
Journal:  EMBO Mol Med       Date:  2009-09       Impact factor: 12.137
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.